However, similar associations of IDO1 and PD-L1 with outcome or pathologic complete response in the neoadjuvant setting, have been observed with bulk transcriptomic profiling in TNBC45, 46 and by conventional immunohistochemistry47 and in other tumor types48. The gene discussed is CD274; the disease is neoplasm.